These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 36986430)
21. Exploration of potential inhibitors for autophagy-related protein 8 as antileishmanial agents. Rahman F; Ali R; Tabrez S; Mobeen A; Akand SK; Arish M; AlAsmari AF; Ali N; Rub A Chem Biol Drug Des; 2022 Jun; 99(6):816-827. PubMed ID: 35147279 [TBL] [Abstract][Full Text] [Related]
22. CYP5122A1 encodes an essential sterol C4-methyl oxidase in Jin Y; Basu S; Feng M; Ning Y; Munasinghe I; Joachim AM; Li J; Madden R; Burks H; Gao P; Perera C; Werbovetz KA; Zhang K; Wang MZ Res Sq; 2023 Jul; ():. PubMed ID: 37546914 [TBL] [Abstract][Full Text] [Related]
23. Structure-based virtual screening, molecular docking, ADMET and molecular simulations to develop benzoxaborole analogs as potential inhibitor against Leishmania donovani trypanothione reductase. Pandey RK; Kumbhar BV; Sundar S; Kunwar A; Prajapati VK J Recept Signal Transduct Res; 2017 Feb; 37(1):60-70. PubMed ID: 27147242 [TBL] [Abstract][Full Text] [Related]
24. Exploring Leishmania donovani 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) as a potential drug target by biochemical, biophysical and inhibition studies. Dinesh N; Pallerla DS; Kaur PK; Kishore Babu N; Singh S Microb Pathog; 2014 Jan; 66():14-23. PubMed ID: 24239940 [TBL] [Abstract][Full Text] [Related]
25. Holanamine, a Steroidal Alkaloid from the Bark of Goel N; Gupta VK; Garg A; Bhoumik A; Biswas R; Natarajan R; Majumder HK; Jaisankar P ACS Infect Dis; 2023 Jan; 9(1):162-177. PubMed ID: 36417798 [TBL] [Abstract][Full Text] [Related]
26. Bestatin analogs-4-quinolinone hybrids as antileishmanial hits: Design, repurposing rational, synthesis, in vitro and in silico studies. Hassan AHE; Mahmoud K; Phan TN; Shaldam MA; Lee CH; Kim YJ; Cho SB; Bayoumi WA; El-Sayed SM; Choi Y; Moon S; No JH; Lee YS Eur J Med Chem; 2023 Mar; 250():115211. PubMed ID: 36827952 [TBL] [Abstract][Full Text] [Related]
27. In Vitro and in Vivo Activity of mTOR Kinase and PI3K Inhibitors Against Phan TN; Baek KH; Lee N; Byun SY; Shum D; No JH Molecules; 2020 Apr; 25(8):. PubMed ID: 32340370 [TBL] [Abstract][Full Text] [Related]
28. Antiprotozoal Activity of Thymoquinone (2-Isopropyl-5-methyl-1,4-benzoquinone) for the Treatment of Qureshi KA; Imtiaz M; Al Nasr I; Koko WS; Khan TA; Jaremko M; Mahmood S; Fatmi MQ Antibiotics (Basel); 2022 Sep; 11(9):. PubMed ID: 36139985 [TBL] [Abstract][Full Text] [Related]
29. Promising antileishmanial activity of novel imidazole antifungal drug luliconazole against Leishmania major: In vitro and in silico studies. Shokri A; Abastabar M; Keighobadi M; Emami S; Fakhar M; Teshnizi SH; Makimura K; Rezaei-Matehkolaei A; Mirzaei H J Glob Antimicrob Resist; 2018 Sep; 14():260-265. PubMed ID: 29793051 [TBL] [Abstract][Full Text] [Related]
30. Antiparasitic dibenzalacetone inhibits the GTPase activity of Rab6 protein of Leishmania donovani (LdRab6), a potential target for its antileishmanial effect. Chauhan IS; Marwa S; Rao GS; Singh N Parasitol Res; 2020 Sep; 119(9):2991-3003. PubMed ID: 32748038 [TBL] [Abstract][Full Text] [Related]
31. Antileishmanial ferrocenylquinoline derivatives: Synthesis and biological evaluation against Leishmania donovani. Yousuf M; Mukherjee D; Dey S; Pal C; Adhikari S Eur J Med Chem; 2016 Nov; 124():468-479. PubMed ID: 27598235 [TBL] [Abstract][Full Text] [Related]
33. Computational studies on potential small molecule inhibitors of Boakye A; Gasu EN; Mensah JO; Borquaye LS J Biomol Struct Dyn; 2023; 41(21):12128-12141. PubMed ID: 36632757 [TBL] [Abstract][Full Text] [Related]
34. Development of a target-free high-throughput screening platform for the discovery of antileishmanial compounds. Corman HN; Shoue DA; Norris-Mullins B; Melancon BJ; Morales MA; McDowell MA Int J Antimicrob Agents; 2019 Oct; 54(4):496-501. PubMed ID: 31323307 [TBL] [Abstract][Full Text] [Related]
35. Molecular Modeling and Virtual Screening Approach to Discover Potential Antileishmanial Inhibitors Against Ornithine Decarboxylase. Pandey RK; Prajapati P; Goyal S; Grover A; Prajapati VK Comb Chem High Throughput Screen; 2016; 19(10):813-823. PubMed ID: 27604958 [TBL] [Abstract][Full Text] [Related]
36. In vitro activity of new N-benzyl-1H-benzimidazol-2-amine derivatives against cutaneous, mucocutaneous and visceral Leishmania species. Nieto-Meneses R; Castillo R; Hernández-Campos A; Maldonado-Rangel A; Matius-Ruiz JB; Trejo-Soto PJ; Nogueda-Torres B; Dea-Ayuela MA; Bolás-Fernández F; Méndez-Cuesta C; Yépez-Mulia L Exp Parasitol; 2018 Jan; 184():82-89. PubMed ID: 29191699 [TBL] [Abstract][Full Text] [Related]